One hundred and sixty-three (163) patients with virus sensitive to Agenerase, at least one other PI, and at least one NRTI were included in PRO30017 substudy A.
Sada kuuskümmend kolm (163) patsienti, kes olid viirustundlikud Agenerase, vähemalt veel ühe PI ja vähemalt ühe NRTI vastu, osalesid PRO30017 alluuringus A.